Skip to main content
Top
Published in: Critical Care 6/2008

Open Access 01-12-2008 | Research

Norepinephrine weaning in septic shock patients by closed loop control based on fuzzy logic

Authors: Mehdi Merouani, Bruno Guignard, François Vincent, Stephen W Borron, Philippe Karoubi, Jean-Philippe Fosse, Yves Cohen, Christophe Clec'h, Eric Vicaut, Carole Marbeuf-Gueye, Frederic Lapostolle, Frederic Adnet

Published in: Critical Care | Issue 6/2008

Login to get access

Abstract

Introduction

The rate of weaning of vasopressors drugs is usually an empirical choice made by the treating in critically ill patients. We applied fuzzy logic principles to modify intravenous norepinephrine (noradrenaline) infusion rates during norepinephrine infusion in septic patients in order to reduce the duration of shock.

Methods

Septic patients were randomly assigned to norepinephrine infused either at the clinician's discretion (control group) or under closed-loop control based on fuzzy logic (fuzzy group). The infusion rate changed automatically after analysis of mean arterial pressure in the fuzzy group. The primary end-point was time to cessation of norepinephrine. The secondary end-points were 28-day survival, total amount of norepinephine infused and duration of mechanical ventilation.

Results

Nineteen patients were randomly assigned to fuzzy group and 20 to control group. Weaning of norepinephrine was achieved in 18 of the 20 control patients and in all 19 fuzzy group patients. Median (interquartile range) duration of shock was significantly shorter in the fuzzy group than in the control group (28.5 [20.5 to 42] hours versus 57.5 [43.7 to 117.5] hours; P < 0.0001). There was no significant difference in duration of mechanical ventilation or survival at 28 days between the two groups. The median (interquartile range) total amount of norepinephrine infused during shock was significantly lower in the fuzzy group than in the control group (0.6 [0.2 to 1.0] μg/kg versus 1.4 [0.6 to 2.7] μg/kg; P < 0.01).

Conclusions

Our study has shown a reduction in norepinephrine weaning duration in septic patients enrolled in the fuzzy group. We attribute this reduction to fuzzy control of norepinephrine infusion.

Trial registration

Trial registration: Clinicaltrials.gov NCT00763906.
Appendix
Available only for authorised users
Literature
1.
go back to reference Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29: 1303-1310. 10.1097/00003246-200107000-00002CrossRefPubMed Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29: 1303-1310. 10.1097/00003246-200107000-00002CrossRefPubMed
2.
go back to reference Annane D, Bellissant E, Cavaillon JM: Septic shock. Lancet 2005, 365: 63-78. 10.1016/S0140-6736(04)17667-8CrossRefPubMed Annane D, Bellissant E, Cavaillon JM: Septic shock. Lancet 2005, 365: 63-78. 10.1016/S0140-6736(04)17667-8CrossRefPubMed
3.
go back to reference Rivers ER, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345: 1368-1377. 10.1056/NEJMoa010307CrossRefPubMed Rivers ER, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345: 1368-1377. 10.1056/NEJMoa010307CrossRefPubMed
4.
go back to reference Bohm M: Catecholamine refractoriness and their mechanisms in cardiocirculatory shock and chronic heart failure. Thorac Cardiovasc Surg 1998, 46: 270-275. 10.1055/s-2007-1013084CrossRefPubMed Bohm M: Catecholamine refractoriness and their mechanisms in cardiocirculatory shock and chronic heart failure. Thorac Cardiovasc Surg 1998, 46: 270-275. 10.1055/s-2007-1013084CrossRefPubMed
5.
go back to reference Abbod MF, Von Keyserlingk DG, Linkens DA, Mahfouf M: Survey of utilisation of fuzzy technology in medicine and healthcare. Fuzzy Sets Systems 2001, 120: 331-349. 10.1016/S0165-0114(99)00148-7CrossRef Abbod MF, Von Keyserlingk DG, Linkens DA, Mahfouf M: Survey of utilisation of fuzzy technology in medicine and healthcare. Fuzzy Sets Systems 2001, 120: 331-349. 10.1016/S0165-0114(99)00148-7CrossRef
6.
go back to reference Held CM, Roy RJ: Multiple drug hemodynamic control by means of a supervisory-fuzzy rule-based adaptive control system: validation on a model. IEEE Trans Biomed Eng 1995, 42: 371-385. 10.1109/10.376130CrossRefPubMed Held CM, Roy RJ: Multiple drug hemodynamic control by means of a supervisory-fuzzy rule-based adaptive control system: validation on a model. IEEE Trans Biomed Eng 1995, 42: 371-385. 10.1109/10.376130CrossRefPubMed
8.
go back to reference Dazzi D, Taddei F, Gavarini A, Uggeri E, Negro R, Pezzarossa A: The control of blood glucose in the critical diabetic patient: a neuro-fuzzy method. J Diabetes Complications 2001, 15: 80-87. 10.1016/S1056-8727(00)00137-9CrossRefPubMed Dazzi D, Taddei F, Gavarini A, Uggeri E, Negro R, Pezzarossa A: The control of blood glucose in the critical diabetic patient: a neuro-fuzzy method. J Diabetes Complications 2001, 15: 80-87. 10.1016/S1056-8727(00)00137-9CrossRefPubMed
9.
go back to reference Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr, Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001, 344: 699-709. 10.1056/NEJM200103083441001CrossRefPubMed Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr, Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001, 344: 699-709. 10.1056/NEJM200103083441001CrossRefPubMed
10.
go back to reference Le Gall JR, Loirat P, Alperovich A, Glaser P, Granthill C, Mathieu D, Mercier PH, Thomas R, Villers D: A simplified acute physiology score for ICU patients. Crit Care Med 1984, 12: 975-977.CrossRefPubMed Le Gall JR, Loirat P, Alperovich A, Glaser P, Granthill C, Mathieu D, Mercier PH, Thomas R, Villers D: A simplified acute physiology score for ICU patients. Crit Care Med 1984, 12: 975-977.CrossRefPubMed
11.
go back to reference Vincent JL, de Mendonca A, Cantraine F, Moreno R, Takala J, Suter PM, Sprung CL, Colardyn F, Blecher S: Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on 'sepsis-related problems' of the European Society of Intensive Care Medicine. Crit Care Med 1998, 26: 1793-1800.CrossRefPubMed Vincent JL, de Mendonca A, Cantraine F, Moreno R, Takala J, Suter PM, Sprung CL, Colardyn F, Blecher S: Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on 'sepsis-related problems' of the European Society of Intensive Care Medicine. Crit Care Med 1998, 26: 1793-1800.CrossRefPubMed
12.
go back to reference Briegel J, Forst H, Haller M, Schelling G, Kilger E, Kuprat G, Hemmer B, Hummel T, Lenhart A, Heyduck M, Stoll C, Peter K: Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single center study. Crit Care Med 1999, 27: 723-732. 10.1097/00003246-199904000-00025CrossRefPubMed Briegel J, Forst H, Haller M, Schelling G, Kilger E, Kuprat G, Hemmer B, Hummel T, Lenhart A, Heyduck M, Stoll C, Peter K: Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single center study. Crit Care Med 1999, 27: 723-732. 10.1097/00003246-199904000-00025CrossRefPubMed
13.
go back to reference Cox DR, Oakes D: Analysis of Survival Data. London, UK: Chapman and Hall; 1984. Cox DR, Oakes D: Analysis of Survival Data. London, UK: Chapman and Hall; 1984.
14.
15.
go back to reference Huang SJ, Shieh JS, Fu M, Kao MC: Fuzzy logic control for intracranial pressure via continuous propofol sedation in a neurosurgical intensive care unit. Med Eng Phys 2006, 28: 639-647. 10.1016/j.medengphy.2005.10.009CrossRefPubMed Huang SJ, Shieh JS, Fu M, Kao MC: Fuzzy logic control for intracranial pressure via continuous propofol sedation in a neurosurgical intensive care unit. Med Eng Phys 2006, 28: 639-647. 10.1016/j.medengphy.2005.10.009CrossRefPubMed
16.
go back to reference Zadeh LA: Fuzzy set. Information Control 1965, 8: 338-353. 10.1016/S0019-9958(65)90241-XCrossRef Zadeh LA: Fuzzy set. Information Control 1965, 8: 338-353. 10.1016/S0019-9958(65)90241-XCrossRef
17.
go back to reference Mahfouf M, Abbod MF, Linkens DA: A survey of fuzzy logic monitoring and control utilisation in medicine. Artif Intell Med 2001, 21: 27-42. 10.1016/S0933-3657(00)00072-5CrossRefPubMed Mahfouf M, Abbod MF, Linkens DA: A survey of fuzzy logic monitoring and control utilisation in medicine. Artif Intell Med 2001, 21: 27-42. 10.1016/S0933-3657(00)00072-5CrossRefPubMed
18.
go back to reference Jasmer RM, Luce JM, Matthay MA: Noninvasive positive pressure ventilation for acute respiratory failure. Chest 1997, 111: 1672-1678. 10.1378/chest.111.6.1672CrossRefPubMed Jasmer RM, Luce JM, Matthay MA: Noninvasive positive pressure ventilation for acute respiratory failure. Chest 1997, 111: 1672-1678. 10.1378/chest.111.6.1672CrossRefPubMed
19.
20.
go back to reference Parrillo JE: Pathogenetic mechanisms of septic shock. N Engl J Med 1993, 328: 1471-1477. 10.1056/NEJM199305203282008CrossRefPubMed Parrillo JE: Pathogenetic mechanisms of septic shock. N Engl J Med 1993, 328: 1471-1477. 10.1056/NEJM199305203282008CrossRefPubMed
21.
go back to reference Bourgoin A, Leone M, Delmas A, Garnier F, Albanese J, Martin C: Increasing mean arterial pressure in patients with septic shock: effects on oxygen variables and renal function. Crit Care Med 2005, 33: 780-786. 10.1097/01.CCM.0000157788.20591.23CrossRefPubMed Bourgoin A, Leone M, Delmas A, Garnier F, Albanese J, Martin C: Increasing mean arterial pressure in patients with septic shock: effects on oxygen variables and renal function. Crit Care Med 2005, 33: 780-786. 10.1097/01.CCM.0000157788.20591.23CrossRefPubMed
22.
23.
go back to reference Bucher M, Kees F, Taeger K, Kurtz A: Cytokines down-regulate alpha1-adrenergic receptor expression during endotoxemia. Crit Care Med 2003, 31: 566-571. 10.1097/01.CCM.0000048621.36569.69CrossRefPubMed Bucher M, Kees F, Taeger K, Kurtz A: Cytokines down-regulate alpha1-adrenergic receptor expression during endotoxemia. Crit Care Med 2003, 31: 566-571. 10.1097/01.CCM.0000048621.36569.69CrossRefPubMed
24.
go back to reference Lei B, Zhang Y, Han C: Sustained norepinephrine stimulation induces different regulation of expression in three alpha1-adrenoceptor subtypes. Life Sci 2001, 69: 301-308. 10.1016/S0024-3205(01)01115-8CrossRefPubMed Lei B, Zhang Y, Han C: Sustained norepinephrine stimulation induces different regulation of expression in three alpha1-adrenoceptor subtypes. Life Sci 2001, 69: 301-308. 10.1016/S0024-3205(01)01115-8CrossRefPubMed
Metadata
Title
Norepinephrine weaning in septic shock patients by closed loop control based on fuzzy logic
Authors
Mehdi Merouani
Bruno Guignard
François Vincent
Stephen W Borron
Philippe Karoubi
Jean-Philippe Fosse
Yves Cohen
Christophe Clec'h
Eric Vicaut
Carole Marbeuf-Gueye
Frederic Lapostolle
Frederic Adnet
Publication date
01-12-2008
Publisher
BioMed Central
Published in
Critical Care / Issue 6/2008
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc7149

Other articles of this Issue 6/2008

Critical Care 6/2008 Go to the issue